Chronic Active Hepatitis Due To Hydroxymethylnitrofurantoin In A Male Patient

References

• Jokela S. Liver disease due to nitrofurantoin. Gastroenterology. 1967; 53: 2 306–11.
   Google Scholar
• Back O, Lundgren R, Lars-Gosta W. Nitrofurantoin-induced pulmonary fibrosis and lupus syndrome. Lancet. 1974; 2: 930.
   Google Scholar
• Klemola H, Penttila O, Runeberg L, Tallqvist G. Anicteric liver damage during nitrofurantoin medication. Scand J Gastroent. 1975; 10: 501–5.
   Google Scholar
• Selroos O, Edgren J. Lupus like syndrome associated with pulmonary reaction to nitrofurantoin. Acta Med Scand. 1975; 197: 125–9.
   Google Scholar
• Lindberg J, Lindholm A, Lundin P, Ivarson S. Trigger factor and HLA antigens in chronic active hepatitis. Brit med J. 1975; 4: 77–9.
   Google Scholar
• Stromberg A, Wengle B. Chronic active hepatitis induced by nitrofurantoin. Brit. Med. J. 1976; 3: 174–5.
   Google Scholar
• Fagrell B, Strandberg I, Wengle B. A nitrofurantoin induced disorder simulating chronic active hepatitis. Acta Med Scand. 1976; 199: 237–9.
   Google Scholar
• Iwarson S, Lindberg J, Lundin P. Nitrofurantoin induced chronic liver disease. Scand J Gastroent. 1979; 14: 497–502.
   Google Scholar
• Marsidi I, Richerson HB, Anuras S. Nitrofurantoin induced chronic active hepatitis. Gastroenterology. 1979; 76: 1291 (Abstract).
   Google Scholar
• Sharp J, Ishak K, Zimmerman HJ. Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin. Ann Intern Med. 1980; 92: 14–9.
   Google Scholar
• Black M, Rabin L, Schatz N. Nitrofurantoininduced chronic active hepatitis. Ann Intern Med. 1980; 92: 62–4.
   Google Scholar
• Hatoff D, Cohen M., Schweigert B, Talbert W. Nitrofurantoin: Another cause of druginduced chronic active hepatitis. Am J Med. 1979; 67: 117–21.
   Google Scholar
• Hannon R, Goslings B. Een geval van geelzucht veroorzaakt door nitrofurantoine. T Geneesk. 1971; 15: 751–6.
   Google Scholar
• Vellenga E., Houthoff HJ, Weits J. Leverbeschadiging door nitrofurantoine. Ned T Geneesk. 1981; 125: 63–6.
   Google Scholar
• Spoelstra P, Janssens AR, Ruiter DJ, Devries RRP. Chronisch actieve hepatitis door nitrofurantoine. Ned T Geneesk. 1981; 125: 61–3.
   Google Scholar
• Offerhaus L, Strieker BHC. Bijwerkingen van nitrofurantoine. Ned T Geneesk. 1982; 126: 915–20.
   Google Scholar
• Ernaelsteen D, Williams R. Jaundice due to Nitrofurantoin. Lancet. 1969; 2: 1369.
   Google Scholar
• Goldstein LI, Ishak K, Burns W. Hepatic injury associated with nitrofurantoin therapy. Am J Dig Dis. 1974; 19: 987–95.
   Google Scholar
• Van Dorpe-Vandewalle N, Fevery J. Toxische hepatitis en longinfiltraten door nitrofurantoine. T Geneesk. 1983; 39: 907–10.
   Google Scholar
• Strohscheer H., Wegener HH. Nitrofurantoininduzierte granulomatose hepatitis. Munch Med Wschr. 1977; 199: 1535.
   Google Scholar
• Sippel PJ, Agger WA. Nitrofurantoin induced granulomatous hepatitis. Urology. 1981; 18: 177–8.
   Google Scholar
• Anttinen H, Aphonen A, Leinonen A, Kallioenen M, Heikkingen E. Diagnostic imaging of Focal Nodular Hyperplasia of the liver developing during nitrofurantoin therapy. Acta Med Scand. 1982; 211: 227–32.
   Google Scholar
• Goldberg SJ, Mendenhall CL, Connell AM, Chedid A. « Nonalcoholic » chronic hepatitis in the alcoholic. Gastroenterology. 1977; 72598–604.
   Google Scholar
• Levin DM, Baker AL, Riddele RH, Rochman H, Boyer JL. Non-alcoholic liver disease-Overlooked causes of liver injury in patients with heavy alcohol consumption. Am J Med. 1979;66:429–34.
   Google Scholar
• Tolman K. Nitrofurantoin and chronic active hepatitis. Ann Intern Med. 1980; 92: 119–20.
   Google Scholar
• Zimmerman HJ. Drug induced chronic hepatic disease. Med Clin North Am. 1979; 63: 567–82.
   Google Scholar
• Teppo AM, Haltia K, Wager O. Immunelec trophoretic «tailing » of albumin line due to albumin-IgG antibody complexes: a side effect of nitrofurantoin treatment. Scand J Immunol. 1976; 5: 249–61.
   Google Scholar
• Holmberg G, Boman G. Pulmonary reactions to nitrofurantoin. Eur J Respir Dis. 1981; 62: 180–9.
   Google Scholar
• Galbraith RM, Eddleston ALWF, Williams R et al. Enhanced antibody responses in active chronic hepatitis: relation to HLA-B 8 and HLA-B 12 and portosystemic shunting. Lancet. 1976; 1: 930–4.
   Google Scholar